It was hard to miss the headlines out of the recent American College of Cardiology meeting in Chicago: Vytorin, the blockbuster cholesterol drug combination from Merck and Schering-Plough ...
Four of the lawsuits also involved Vytorin, a combination drug containing Zetia. The plaintiffs had accused Glenmark of participating in anti-competitive practices in 2010 in a patent dispute ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback